Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection

T. Southworth (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Mowbray (Cambridge MA, United States of America), R. Strieter (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland), D. Singh (Manchester, United Kingdom)

Source: International Congress 2018 – New pharmacological strategies in airway diseases
Session: New pharmacological strategies in airway diseases
Session type: Oral Presentation
Number: 517
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Southworth (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Mowbray (Cambridge MA, United States of America), R. Strieter (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland), D. Singh (Manchester, United Kingdom). Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection. 517

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations
Source: International Congress 2019 – Airway physiology
Year: 2019


Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013


Human rhinovirus (HRV) induced changes in mild asthma: Time course of clinical and inflammatory biomarker changes
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016



Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020


Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Late Breaking Abstract - Systemic IL-26 correlates with improved asthma control in children with allergic sensitization
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018

Late Breaking Abstract - CPAP is effective in treating COVID-19 patients with Type 1 respiratory failure.
Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care
Year: 2020




Late Breaking Abstract - Temporal relationships of cytokines, chemokines and cellular biomarkers during Human Rhinovirus (HRV) infection in asthmatics
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019



Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors.
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017

Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018




Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Time course relationships of Type 1 and 2 inflammatory and innate immune pathways during Human Rhinovirus (HRV) infection in subjects with asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018


Association between human rhinovirus C and severity of acute asthma in children
Source: Eur Respir J 2011; 37: 1037-1042
Year: 2011



Infection with HRV-C during acute asthma in adults is associated with increased sputum neutrophils and self-reported severity of symptoms
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Late Breaking Abstract - Enhanced expression of IL-1ß in later stage of influenza A virus infection is independent of NLRP3 in vitro
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020


Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019